Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Chantui Zhike Granules for acute tracheobronchitis-associated cough
CTR20254200Phase 3Active
- Sponsor
- Henan Provincial Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Nov 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute bronchitis comparing Chantui Zhike Granules with Placebo comparator (2 arms). Primary endpoint: Cough disappearance rate. Started Nov 2025; status: active.
02
Drugs
Chantui Zhike Granules
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on CTR20254200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254200.